Pfizer (NYSE: PFE) and Moderna (NASDAQ: MRNA) are waiting on pins and needles to receive emergency use authorizations (EUA) for their COVID-19 vaccines. And investors are anxiously awaiting the big financial impact these vaccines will make on the companies' top and bottom lines. In this Motley Fool Live video recorded on Dec. 3, 2020, Healthcare and Cannabis Bureau Chief Corinne Cardina and Fool.com writer Keith Speights discuss when Pfizer and Moderna are likely to be able to record revenue from their COVID vaccines.

Continue reading

Source Fool.com